Search

everythinglearnresearchcommunity

for

Search:↓

Alopecia areata, a type of hair loss, is likely an autoimmune disease with a genetic link, but its exact cause is still unknown.

A young woman had a rare skin reaction to a medication for her joint disease, and a combination therapy improved her condition.

HO-1 helps skin health and healing but can worsen melanoma; it's a potential treatment target for skin diseases.

Combining imiquimod with diphenylcyclopropenone may improve treatment outcomes for alopecia areata patients who don't respond to diphenylcyclopropenone alone.

Chemotherapy often causes hair loss, which usually grows back within 3 to 6 months, but there's no effective treatment to prevent it.

Hair loss improved with treatment and successful transplant.

Botulinum toxin type A significantly reduces scalp psoriasis severity compared to placebo.

Red blood cell folate levels are reliable indicators of long-term folate status in alopecia areata patients.

Canine pemphigus foliaceus involves significant immune activity and shares similarities with human pemphigus.

Cyclosporine cleared a woman's resistant skin condition quickly and kept it away for over a year.

Systemic immunotherapies are used for immune-related hair loss but not usually for genetic hair loss, unless the patient has both conditions.

Adalimumab is the most effective treatment for severe hidradenitis suppurativa, but more research is needed to improve treatment options.

Baricitinib and ritlecitinib are recommended for severe alopecia areata, with other treatments available off-label.

Sulfasalazine can cause severe allergic reactions leading to long-term autoimmune issues like hair loss and skin discoloration.

Dupilumab improved severe atopic dermatitis in a patient who didn't respond to other treatments.

Different treatments for skin conditions were found to be effective and generally safe, with biologics recommended as the first choice for generalized pustular psoriasis.

Macrophage activation syndrome can be a deadly first sign of systemic lupus erythematosus.

A 62-year-old woman with hair loss and scalp itching was diagnosed with lichen planopilaris, treated initially with topical corticosteroids, and other possible treatments include systemic steroids, antimalarials, and more.

The Polish Society of Dermatology recommends treatments for alopecia areata that vary by severity, including topical and systemic medications, with long-term maintenance important for management.

Alopecia Areata is an autoimmune hair loss condition, with various treatments showing mixed effectiveness and no guaranteed cure.

Some skin medications are safe during pregnancy and breastfeeding, but others can harm the baby and should be avoided.

Most dermatologic medications are safe during pregnancy and breastfeeding, but some should be avoided due to potential risks.

Severe anti-TNF-α induced scalp eruptions often need stopping the drug and using systemic therapy to avoid scarring.

Skin problems from transplant drugs are common and need careful management in organ transplant patients.

Some skin medications are safe for pregnant women, but others pose risks or should not be used.

Hair loss from Alopecia Areata is caused by both genes and environment, with several treatments available but challenges in cost and relapse remain.

Platelet-rich plasma treatment is not very effective for chronic severe alopecia areata.

Early treatment is key for permanent hair loss disorders, with options ranging from medications and phototherapy to immunomodulators and antibiotics, depending on severity and type.

Minoxidil and oral antioxidants helped improve hair growth in a patient with hair loss due to lupus.

The most effective treatments for hair loss are minoxidil, finasteride, PRP, and hair transplants, with steroids and immunosuppressants for autoimmune types.